bpc 157 fda ind or nda An advisory panel voted on BPC-157 today., That does not mean BPC-157 was FDA approved., The panel recommended that BPC-157 be considered for addition to a list of substances that may be used by TLDR; no. BPC-157 is a
TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on FDA's Overreach on Compounded Peptides BPC 157 Legal Status: FDA Regulations and Compounding The date is locked in for LGMD2I R9. The FDA has accepted our NDA for BBP 418 for LGMD2I R9, with a PDUFA target action date of November 27, 2026. For a community that has BPC 157 FDA Approval Status 2026: Clinical Trials
Pay in 4 interest-free payments of $5.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3


